Inoverm Total δισκία για σκύλους
Inoverm Total δισκία για σκύλους
Authorised
- Fenbendazole
- Praziquantel
- Pyrantel embonate
Product identification
Medicine name:
Inoverm Total δισκία για σκύλους
Active substance:
- Fenbendazole
- Praziquantel
- Pyrantel embonate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Fenbendazole200.00/milligram(s)1.00Tablet
-
Praziquantel50.00/milligram(s)1.00Tablet
-
Pyrantel embonate144.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratoires Biove
Marketing authorisation date:
Manufacturing sites for batch release:
- Pernix Pharma Kft.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 51469/19-05-2022/K-0250901
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet